Bollard Group LLC - ITERUM THERAPEUTICS PLC ownership

ITERUM THERAPEUTICS PLC's ticker is ITRM and the CUSIP is G6333L101. A total of 39 filers reported holding ITERUM THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of ITERUM THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$07240.0%0.00%
Q4 2021$07240.0%0.00%
Q3 2021$0
-100.0%
7240.0%0.00%
Q2 2021$2,000
+100.0%
7240.0%0.00%
Q1 2021$1,0000.0%7240.0%0.00%
Q4 2020$1,0000.0%7240.0%0.00%
Q3 2020$1,000
-75.0%
724
-75.9%
0.00%
Q2 2020$4,0003,0100.00%
Other shareholders
ITERUM THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,538,316$10,307,0001.89%
New Leaf Venture Partners, L.L.C. 1,456,303$9,648,0001.76%
Sofinnova Investments, Inc. 1,726,514$11,438,0001.02%
Cormorant Asset Management, LP 476,968$3,196,0000.21%
Granahan Investment Management 250,717$1,661,0000.09%
TIVERTON ASSET MANAGEMENT LLC 140,448$941,0000.05%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 100,000$670,000,0000.02%
Neuburgh Advisers LLC 61,676$413,0000.01%
Flinton Capital Management LLC 50,792$340,0000.01%
Tyers Asset Management LLC 39,908$268,0000.01%
View complete list of ITERUM THERAPEUTICS PLC shareholders